Winship treats first lung cancer patient with T-cell receptor

PDF) JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer

Frontiers Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ

Winship Magazine - Spring 2022 by EmoryWeb - Issuu

Winship Weekly Winship Cancer Institute

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Trastuzumab Deruxtecan for HER2+ Gastric Cancer

History of Winship Winship Cancer Institute

Winship Roundup

Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis

Improving Health Care for Every Patient with Epilepsy

Spring/Summer 2020 Emory Health Digest